Literature DB >> 31895670

Impact of Multi-Drug-Resistant Pneumonia on Outcomes of Critically Ill Trauma Patients.

Ishita Rai1, Andrew H Stephen1, Qing Lu1, Daithi S Heffernan1.   

Abstract

Background: Rates of infections with multi-drug-resistant organisms (MDROs) are increasing among critically ill patients. Among non-surgical patients, MDROs increase directly the risk of adverse secondary events including death. However, similar effects do not appear to occur among surgical patients. Specifically, among critically injured trauma patients, it is unknown whether degree of injury versus the presence of an MDRO increases the risk of death.
Methods: This is a retrospective chart review of admitted adult trauma patients. Data included demographics, medical comorbidities, injury severity score, infections, occurrence of pneumonia including microbiology sensitivity profile, hospital course, and outcomes.
Results: Patients requiring adminission to the intensive care unit (ICU) were more severely injured with greater degree of thoracic and head trauma and had a greater burden of pre-trauma medical comorbidities. Among those admitted to the ICU, 93 patients developed pneumonia. Patients who developed pneumonia were younger and more severely injured, with higher rates of thoracic and head injuries and higher rates of smoking. Development of pneumonia was associated with worse outcomes. However, among patients with pneumonia, comparing MDRO to pan-sensitive (PanSens) infections, PanSens infection occurred earlier and were more likely associated with pre-trauma smoking status. There was no difference in injury patterns, medical comorbidities, or outcomes.
Conclusion: The development of pneumonia among trauma patients reflects degree of injury and underlying medical status. However, development of MDRO versus PanSens pneumonia did not affect trauma-related outcomes further. This information will guide family discussions and critical care decisions better among vulnerable trauma patients.

Entities:  

Keywords:  MRSA; multi-drug resistant; pneumonia; surgical; trauma

Mesh:

Substances:

Year:  2020        PMID: 31895670      PMCID: PMC7247025          DOI: 10.1089/sur.2019.240

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  26 in total

Review 1.  How to stratify patients at risk for resistant bugs in skin and soft tissue infections?

Authors:  Cristina Vazquez Guillamet; Marin H Kollef
Journal:  Curr Opin Infect Dis       Date:  2016-04       Impact factor: 4.915

2.  Infections caused by multidrug resistant organisms are not associated with overall, all-cause mortality in the surgical intensive care unit: the 20,000 foot view.

Authors:  Laura H Rosenberger; Damien J LaPar; Robert G Sawyer
Journal:  J Am Coll Surg       Date:  2012-03-13       Impact factor: 6.113

3.  Is ventilator-associated pneumonia in trauma patients an epiphenomenon or a cause of death?

Authors:  Louis J Magnotti; Martin A Croce; Timothy C Fabian
Journal:  Surg Infect (Larchmt)       Date:  2004       Impact factor: 2.150

4.  Trauma deaths in a mature urban trauma system: is "trimodal" distribution a valid concept?

Authors:  Demetrios Demetriades; Brian Kimbrell; Ali Salim; George Velmahos; Peter Rhee; Christy Preston; Ginger Gruzinski; Linda Chan
Journal:  J Am Coll Surg       Date:  2005-09       Impact factor: 6.113

5.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Authors:  E Lautenbach; J B Patel; W B Bilker; P H Edelstein; N O Fishman
Journal:  Clin Infect Dis       Date:  2001-03-26       Impact factor: 9.079

6.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis.

Authors:  Sara E Cosgrove; George Sakoulas; Eli N Perencevich; Mitchell J Schwaber; Adolf W Karchmer; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2002-12-13       Impact factor: 9.079

Review 7.  Epidemiology of methicillin-resistant Staphylococcus aureus.

Authors:  Helen W Boucher; G Ralph Corey
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

Review 8.  The negative impact of antibiotic resistance.

Authors:  N D Friedman; E Temkin; Y Carmeli
Journal:  Clin Microbiol Infect       Date:  2015-12-17       Impact factor: 8.067

Review 9.  Chronic Respiratory Infection in Patients with Chronic Obstructive Pulmonary Disease: What Is the Role of Antibiotics?

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Mol Sci       Date:  2017-06-23       Impact factor: 5.923

Review 10.  Antibiotic resistance: it's bad, but why isn't it worse?

Authors:  Nicholas Waglechner; Gerard D Wright
Journal:  BMC Biol       Date:  2017-09-15       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.